Patent details

EP3551629 Title: OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3551629
WO Application Number:
US2017065270
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17879038.2
WO Publication Number:
WO2018107004
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
08/12/2017
Grant date:
15/11/2023
EP Publication Date:
16/10/2019
WO Publication Date:
14/06/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
07/02/2024
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/11/2023
EP B1 Publication Date:
15/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
07/12/2037
Lapsed By Expiration Date:
Patent Validated Date:
15/02/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
04/06/2024
 
 

 

Name:
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer National Institutes of Health 6701 Rockledge Drive, Suite 700, 20892, Bethesda, MD, United States of America (US)

From:
15/11/2023
 
 

 

Name:
Lixte Biotechnology, Inc.
Address:
680 E. Colorado Blvd., Suite 180, Pasadena, CA 91101, United States of America (US)

Historical Applicant/holder

From:
15/11/2023
To:
04/06/2024

 

Name:
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States of America (US)

Agent

Name:
ir. W.J.J.M. Kempes
From:
14/02/2024
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
KOVACH, John S.
Address:
East Setauket, New York 11733, United States of America (US)

2

Name:
ZHUANG, Zhengping
Address:
Bethesda, Maryland 20814, United States of America (US)

3

Name:
HO, Sze Chun Winson
Address:
6011 Executive Boulevard Suite 325, MSC 7660 Bethesda, Maryland 20892-7660, United States of America (US)

4

Name:
WANG, Herui
Address:
6011 Executive Boulevard Suite 325, MSC 7660 Bethesda, Maryland 20892-7660, United States of America (US)

5

Name:
LU, Rongze
Address:
Sunnyvale, CA 94085, United States of America (US)

Priority

1

Priority Patent Number:
201762545373 P
Priority Date:
14/08/2017
Priority Country:
United States of America (US)

2

Priority Patent Number:
201762465001 P
Priority Date:
28/02/2017
Priority Country:
United States of America (US)

3

Priority Patent Number:
201662497949 P
Priority Date:
08/12/2016
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C07D 471/04; C07D 405/14; A61K 31/4439; A61K 9/00; A61K 31/4525; A61K 39/395; A61K 45/06; A61P 35/00; C07K 16/28; A61K 39/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
08/24
Publication date:
21/02/2024
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
46/23
Publication date:
15/11/2023
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202346
Publication date:
15/11/2023
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202401020A
Date Registered:
04/06/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
RWS Group (RW Translations Limited)
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/12/2025
Annual Fee Number:
9
Annual Fee Amount:
340 Euro
Last Annual Payment Date:
19/12/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
14/02/2024 Outgoing Correspondence Letter no formal defects 1 PDF /7/2/5/2/4/0800942527/docs/ep17879038.2_1_592125l271.pdf
07/02/2024 Claims First filed claims 7 PDF /7/2/5/2/4/0800942527/docs/ep17879038.2_0_claims20240207114509352.pdf